ForeverLabs
servicesprovidersmission
Schedule a consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Diabetes
AI generated image for: Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications
Clinical
Aug 11, 2025
1 min read
PubMed
Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications
Cell-based therapies including pluripotent and multipotent adult stem cells show proven repair and regeneration potential and are being considered as a remedy for diabetic complications, which are the most prominent reason for high mortality among diabetic patients. They may also provide a long-term cure for diabetes and its complications.
MetabolicDiabetes
AI generated image for: A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
Clinical
Aug 11, 2025
1 min read
PubMed
A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
No alternative intervention strategies match, or even get close to, the clinical outcome achieved in a considerable number of patients treated with autologous stem cell transplantation. We propose that this patient group should be identified, diligently informed and offered the possible benefits of an extended period of insulin-free and burden-free survival,
BloodDiabetes

Stay in touch

Shop

Annual planLifetime PlanClient Login

Learn

ArticlesBlogFAQ

Careers

About usPrivacy PolicyPressTerms of Service

For Clinics

Scheduler LoginFor PhysiciansPartner With UsContact Us
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTube

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.